October 4, 2019
Authored and Edited by Michelle G. Rice; Sydney R. Kestle; Elizabeth D. Ferrill
In Curver Luxembourg, SARL v. Home Expressions Inc., No. 2018-2214 (Fed. Cir. Sep. 12, 2019), the Federal Circuit held claim language could limit the scope of a design patent to a specific article of manufacture where the claim language supplies the only instance of an article of manufacture that appears nowhere in the figures.
Curver owns a design patent that claims an “ornamental design for a pattern for a chair” and has figures that do not show a chair. Curver asserted that Home Expressions’ baskets incorporating the design infringed. Home Expressions moved to dismiss the complaint, arguing that the design patent claim was limited to chairs and, thus, its baskets fell outside the scope of the claim. The district court agreed and dismissed the complaint.
On appeal, the Federal Circuit held that the district court properly construed the claim as limited to chairs and affirmed the dismissal of the complaint. It reasoned that its own precedent, the unchallenged governing regulation, and agency practice do not sanction granting a patent on a surface ornamentation per se; rather, the surface ornamentation must be tethered to an article of manufacture. While acknowledging that courts typically look to the figures to define the scope of a design patent claim, the Court held it could not ignore the only identification of an article of manufacture recited in the claim itself.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Panel Discussion
May 5, 2026
London
At the PTAB Blog
Revvo‑lution in Discretionary Denial: Claim Construction Consistency Takes Center Stage
April 28, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.